IV BioHoldings

We are a bio-innovation studio specializing in de novo company creation at the intersection of diagnostics and life sciences. We take a multidisciplinary approach to building companies; cross-pollinating ideas and experiences across multiple industries, breaking down silos, disrupting healthcare R&D processes, and rethinking entrepreneurial models. We leverage strong partnerships and advanced analytical science to gain deeper insights into human biology to fundamentally improve the detection, diagnosis, and treatment of diseases. The current IVBH ecosystem includes three transformative biotech startups: LiquidLung, Inc., HepGene, Inc., and Mammogen, Inc., which focus on pulmonary diseases, metabolic disorders, and women's health, respectively.